FDA-approved for type 2 diabetes and for reducing the risk of major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease
Signs You May Benefit from Medically-Supervised GLP-1 Weight Loss Injections Diet and exercise aren't producing results Weight gain despite eating less Constant hunger and food preoccupation Previous weight loss attempts failed Regained weight after initial success Hormonal changes affecting weight Perimenopause or menopause weight gain Insulin resistance or prediabetes Thyroid dysfunction Metabolic slowdown in 40s+ If you're experiencing challenges listed above, GLP-1 weight loss injections with medical supervision could help you
Note: The Medicaid version of the BALANCE Model is still launching in May 2026, but that is entirely separate from Medicare Part D
Its rich content in monounsaturated fatty acids and PUFAs, as well as antioxidants, polyphenols, and dietary fibre, underlies its multi-targeted benefits, many of which may synergise with pharmacotherapies such as semaglutide to optimise clinical outcomes [112]
Ask Before You Choose: when the intro price ends, renewal price, dose-related changes, and refill timing
It is not FDA-approved as a product the way brand-name versions are, and quality depends on the pharmacy, which is why provider sourcing matters